FamiCord AG (VTIAF)

Market Cap	94.79M +22.1%
Revenue (ttm)	103.59M +9.5%
Net Income	-11.50M
EPS	-0.69
Shares Out	n/a
PE Ratio	n/a
Forward PE	63.29
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	712
Open	6.38
Previous Close	6.38
Day's Range	6.38 - 6.38
52-Week Range	4.57 - 9.00
Beta	0.70
RSI	34.30
Earnings Date	Apr 30, 2026

About FamiCord AG

FamiCord AG engages in the collection, processing, cryopreservation, and storage of stem cells from umbilical cord blood and tissue and postnatal tissue in Germany, Poland, Portugal, and internationally. It operates through Subgroup Vita 34 And Subgroup PBKM segments. The company produces and develops advanced therapies, genetic tests, and analyses for third parties. It also develops products and drugs based on cells, tissues, and blood for medical applications; and produces and manufactures viral vectors and CAR-T cells. In addition, the compa...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1997
• Employees: 766
• Stock Exchange: OTCMKTS
• Ticker Symbol: VTIAF

Financial Performance

In 2024, FamiCord AG's revenue was 82.18 million, an increase of 6.65% compared to the previous year's 77.06 million. Losses were -12.14 million, 550.7% more than in 2023.

Financial numbers in EUR